Shionogi completes new $247 million research facility

Japanese drug major Shionogi (TKO: 4507)last week held an inauguration ceremony of the new pharmaceutical research building, which was constructed on the grounds of the company's existing laboratories located in Toyonaka City, Osaka, where this building, which has cost 18.9 billion yen ($247 million),  will become the central core of Shionogi's research operations.

With the completion of the new facility, Shionogi's drug discovery research operations, which were previously distributed amongst four sites in Osaka and Shiga Prefectures, are now integrated into the Shionogi Pharmaceutical Research Center (referred to as “SPRC (spark)”), which is composed of the new building and the existing three buildings. Shionogi aims to achieve world-leading research productivity, aided by enhanced coordination among the integrated functions at SPRC.

The new building contains drug discovery research laboratories built to the highest standard, with cutting-edge laboratory equipment and information technology capabilities. At the same time, the facility is environmentally-sensitive and incorporates a specially-designed layout designed to stimulate creativity and support innovation by increasing communication and mutual collaboration among researchers.